Published in
Elsevier, European Journal of Cancer, (161), p. 99-107, 2022
DOI: 10.1016/j.ejca.2021.11.009
Links
Tools
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Journal article published in 2022 by
Carl M. Thielmann,
Johanna Matull,
Anne Zaremba,
Rajmohan Murali,
Eleftheria Chorti,
Georg Lodde 
,
Philipp Jansen,
Rudolf Herbst ,
Patrick Terheyden ,
Jochen Utikal,
Claudia Pföhler,
Jens Ulrich,
Alexander Kreuter ,
Peter Mohr ,
Ralf Gutzmer
and other authors.
,
Philipp Jansen,
Rudolf Herbst ,
Patrick Terheyden ,
Jochen Utikal,
Claudia Pföhler,
Jens Ulrich,
Alexander Kreuter ,
Peter Mohr ,
Ralf Gutzmer
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 